Back to RPRX
LANSDOWNE PARTNERS (UK) LLP → RPRX
LANSDOWNE PARTNERS (UK) LLP RPRX Position History
Royalty Pharma plc
Quarters held
10
Latest value
$32.2M
Q2 2026
Peak value
$50.6M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $15.8M |
| Q1 2026 | $48.3M |
| Q1 2026 | $50.6M |
| Q1 2026 | $19.6M |
| Q1 2026 | $17.8M |
| Q2 2026 | $19.3M |
| Q2 2026 | $15M |
| Q2 2026 | $40.3M |
| Q2 2026 | $12.2M |
| Q2 2026 | $32.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $32.2M | 691.7K | — | — |
| Q2 2026 | $12.2M | 262.7K | — | — |
| Q2 2026 | $40.3M | 867.1K | — | — |
| Q2 2026 | $15M | 322.5K | — | — |
| Q2 2026 | $19.3M | 416.0K | — | — |
| Q1 2026 | $17.8M | 346.0K | — | — |
| Q1 2026 | $19.6M | 381.9K | — | — |
| Q1 2026 | $50.6M | 983.8K | — | — |
| Q1 2026 | $48.3M | 939.4K | — | — |
| Q1 2026 | $15.8M | 306.6K | — | — |